Vitamin levels in Behçet's disease

Journal of Dermatological Treatment

Volumn 18, Issue 2, 2007, Pages 69-75

  Kandi, Basak ^a   Cicek, Demet ^a   Ilhan, Nevin ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; MDA; NO; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FLAVINE MONONUCLEOTIDE; MALONALDEHYDE; NITRIC OXIDE; THIAMINE; VITAMIN;

ADULT; AGED; ARTICLE; BEHCET DISEASE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL;

ADULT; AGED; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; VITAMINS;

EID: 34249038652     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630601156355     Document Type: Article

References (46)

1. Behçet H. Uber rezidivierende apthose, durch ein virus verursachte geschwure am mund, am auge und an den genitalien. Dermatol Wochenschr. 1937;105:1152-7.
2. Watanabe K, Ohashi Y. Natural killer cell activity in patients with Behcets disease. Am J Ophthalmol. 1984;98:813-14.
3. Multu S, Scully C. The person behind the eponym: Hulusi Behçet (1889-1948). J Oral Pathol Med. 1994;23:289-90.
4. Sakane T, Takeno M, Suzuki N, et al. Behcets disease. N Engl J Med. 1999;341:1284-91.
5. Ghate JV, Jorizzo JL. Behcets disease, and complex aphthosis. J Am Acad Dermatol. 1999;40:1-18.
6. Zouboulis CC. Epidemiology of Adamantiades-Behcets disease. Ann Med Interne. 1999;150:488-98.
7. Direskeneli H. Behcets disease: Infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001;60:996-1002.
8. Yamashita N. Hyperreactivity of neutrophils and abnormal T cell homeostasis: A new insight for pathogenesis of Behcets disease. Int Rev Immunol. 1997;14:11-19.
9. Lehner T. Immunopathogenesis of Behcets disease. Ann Med Interne. 1999;150:483-7.
10. Alpsoy E, Kodelja V, Goerdt S, et al. Serum of patients with Behcets disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology. 2003;206:225-32.
11. Mege JL, Dilsen N, Sanguedolce V, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin-6, IL-8 and increased neutrophil superoxide generation in Behcets disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544-9.
12. Pronai L, Ichikawa Y, Nakazawa H, et al. Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leucocytes in Behcets disease - effects of colchicine. Clin Exp Rheumatol. 1991;9:227-33.
13. Carletto A, Pacor ML, Biasi D, et al. Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behcets disease. J Rheumatol. 1997;24:1332-6.
14. Takeno M, Kariyone A, Yamashita N, et al. Excessive function of peripheral blood neutrophils from patients with Behcets disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995;38:426-33.
15. Tuzun B, Tuzun Y, Mat C, et al. Neutrophil chemotaxis in Behcets syndrome. Ann Rheum Dis. 1999;58:658.
16. Özgün S, Akoglu T, Direskeneli H, et al. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behcets disease. Ann Rheum Dis. 1996;55:128-33.
17. Niwa Y, Miyake S, Sakane T, et al. Auto-oxidative damage in Behcets disease: Endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol. 1982;49:247-55.
18. Orem A, Efe H, Deger O, et al. Relationship between lipid peroxidation and disease activity in patients with Behcets disease. Dermatol Sci. 1997;16:11-16.
19. Kose K, Dogan P, Ascioglu M, et al. Oxidative stress and antioxidant defenses in plasma of patients with Behcets disease. Tohoku J Exp Med. 1951;76:239-48.
20. Noyan T, Şahin İ, Şekeroǧlu MR, et al. The serum vitamin C levels in Behcets disease. Yonsei Med J. 2003;44:771-8.
21. Erel A, Özsoy E, Biberoǧlu G, et al. Serum levels of vitamins A,C, and E, β-carotene, selenium and zinc in patients with Behcets disease. Biol Trace Elem Res. 2003;95:97-106.
22. Saǧlam K, Serçe AF, Yilmaz MI, et al. Trace elements and antioxidant enzymes in Behcets disease. Rheumatol Int. 2002;22:93-6.
23. Shils ME, Olson JA, Shiike M. Modern nutrition. In: Health and disease. Philadelphia, PA: Lea and Febiger; 1994. p. 875-9.
24. Goodman DS. Vitamin A and retinoids in health and disease. N Engl J Med. 1984;310:1023.
25. Farrell AJ, Blake DR. Nitric oxide. Ann Rheum Dis. 1996;55:7-20.
26. Evereklioglu C, Turkoz Y, Er H, et al. Increased nitric oxide production in patients with Behcets disease: Is it a new activity marker? J Am Acad Dermatol. 2002;46:50-4.
27. Parks DJ, Cheung MK, Chan CC, et al. The role of nitric oxide in uveitis. Arch Ophthalmol. 1994;112:544-6.
28. Studer R, Jaffurs D, Stefanovic-Racic M, et al. Nitric oxide in osteoarthritis. Osteoarthritis Cartilage. 1999;7:377-9.
29. Izgut-Uysal VN, Ozkaya YG, Ozdemir S, et al. Effect of Larginine on age-related changes in macrophage phagocytic activity. Immunol Invest. 2004;33:287-93.
30. Granger DL, Taintor RR, Boockvar KS, et al. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol. 1996;268:142-51.
31. Criteria for diagnosis of Behcet's disease, International Study Group for Behcet's disease. Lancet. 1990;335:1078-80.
32. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37-43.
33. Kökçam I, Naziroǧlu M. Effect of vitamin E supplementation on blood antioxidants levels in patients with Behcets disease. Clin Biochem. 2002;35:633-9.
34. Ravid A, Koren R. The role of reactive oxygen species in the anticancer activity of vitamin D. Recent Results Cancer Res. 2003;164:357-67.
35. Sokol RJ. Vitamin E deficiency and neurologic disease. Annu Rev Nutr. 1988;8:351-73.
36. Tabet N, Mantle D, Walker Z, Orrell M. Vitamins, trace elements, and antioxidant status in dementia disorders. Int Psychogeriatr. 2001;13:265-75.
37. Ullegaddi R, Powers HJ, Gariballa SE. B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke. Clin Sci. 2004;107:477-84.
38. Bekpinar S, Koçak H, Ünlüçeral Y, et al. The evaluation of C-reactive protein, homocysteine and vitamin B6 concentrations in Behçet and rheumatoid arthritis disease. Clin Chim Acta. 2003;329:143-5.
39. Çal?koǧlu E, Öztaş M, Şengül N, et al. Serum homocysteine level in Behcets disease. Hematologia. 2002;32:219-24.
40. Ward M. Homocysteine, folate, and cardiovascular disease. Int J Vitam Nutr Res. 2001;71:173-8.
41. Korkmaz C, Bozan B, Koşar M, et al. Is there an association of plasma homocysteine levels with vascular involvement in patients with Behcets syndrome. Clin Exp Rheumatol. 2002;20:30-4.
42. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, controls. Cell. 1994;78:915-18.
43. Osborne NN, Barnett NL, Herrera AJ. NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. Brain Res. 1993;610:194-8.
44. Henson PM, Johnston RB. Tissue injury and inflammation. J Clin Invest. 1987;79:669-74.
45. Köse K, Doǧan P, Aşc?oǧlu M, et al. Oxidative stress and antioxidant defenses in plasma of patients with Behcets disease. Tohoku J Exp Med. 1995;176:239-48.
46. Freitas JP, Filipe P, Yousefi A, et al. Oxidative stress in Adamantiades-Behcets disease. Dermatology. 1998;197:43-8.